Experimental evaluation of antiarrhythmic drugs in the guinea pig.
D031841:Aconitum; D000404:Ajmaline / Q000627:therapeutic use; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000188:drug therapy*; D001949:Bretylium Compounds / Q000627:therapeutic use; D006168:Guinea Pigs; D008012:Lidocaine / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011342:Procainamide / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013328:Strophanthins; D014700:Verapamil / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D013328:Strophanthins; D000404:Ajmaline; D010672:Phenytoin; D008012:Lidocaine; D011433:Propranolol; D014700:Verapamil; D011802:Quinidine; D011342:Procainamide